Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Ljungman

Showing results (51-60 of 320) with videos related to

Pageof 32
Sort By:
Journal of Cancer Survivorship : Research and Practice|January 8, 2021
Important factors associated with sick leave after allogeneic haematopoietic stem cell transplantation-a 1-year prospective studyLinda Eriksson, Agneta Wennman-Larsen, Karin Bergkvist, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 9, 2017
Impact of Pretransplantation Indices in Hematopoietic Stem Cell Transplantation: Knowledge of Center-Specific Outcome Data Is Pivotal before Making Index-Based DecisionsJohan Törlén, Mats Remberger, Katarina Le Blanc, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 15, 2010
Leukemia lineage-specific chimerism analysis and molecular monitoring improve outcome of donor lymphocyte infusionsDarius Sairafi, Mats Remberger, Michael Uhlin, et al.
Blood|August 23, 2003
Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysisPer Ljungman, Ronald Brand, Hermann Einsele, et al.
The Journal of Infection|February 8, 2008
Identification of species of viridans group streptococci in clinical blood culture isolates by sequence analysis of the RNase P RNA gene, rnpBKatarina Westling, Inger Julander, Per Ljungman, et al.
Clinical Transplantation|October 26, 2019
Bone and hormonal status 10 years post-allogeneic bone marrow transplantationDanica Gubrianska, Maciej Machaczka, Moustapha Hassan, et al.
Transplantation|April 16, 2004
Reduced risk for extensive chronic graft-versus-host disease in patients receiving transplants with human leukocyte antigen-identical sibling donors given polymerase chain reaction-based preemptive therapy against cytomegalovirusKajsa Larsson, Johan Aschan, Mats Remberger, et al.
Pediatric Blood & Cancer|July 11, 2020
A prospective study on the long-term outcome of prepubertal and pubertal boys undergoing testicular biopsy for fertility preservation prior to hematologic stem cell transplantationBirgit Borgström, Margareta Fridström, Britt Gustafsson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 18, 2016
Risk Factors for Invasive Mold Infections and Implications for Choice of Prophylaxis after Allogeneic Stem Cell TransplantationOla Blennow, Mats Remberger, Johan Törlén, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2014
Varicella-zoster reactivation after allogeneic stem cell transplantation without routine prophylaxis--the incidence remains highOla Blennow, Gustav Fjaertoft, Jacek Winiarski, et al.
Pageof 32

Showing results (51-60 of 320) with videos related to

Sort By:
Pageof 32
Journal of Cancer Survivorship : Research and Practice|January 8, 2021
Important factors associated with sick leave after allogeneic haematopoietic stem cell transplantation-a 1-year prospective studyLinda Eriksson, Agneta Wennman-Larsen, Karin Bergkvist, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 9, 2017
Impact of Pretransplantation Indices in Hematopoietic Stem Cell Transplantation: Knowledge of Center-Specific Outcome Data Is Pivotal before Making Index-Based DecisionsJohan Törlén, Mats Remberger, Katarina Le Blanc, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 15, 2010
Leukemia lineage-specific chimerism analysis and molecular monitoring improve outcome of donor lymphocyte infusionsDarius Sairafi, Mats Remberger, Michael Uhlin, et al.
Blood|August 23, 2003
Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysisPer Ljungman, Ronald Brand, Hermann Einsele, et al.
The Journal of Infection|February 8, 2008
Identification of species of viridans group streptococci in clinical blood culture isolates by sequence analysis of the RNase P RNA gene, rnpBKatarina Westling, Inger Julander, Per Ljungman, et al.
Clinical Transplantation|October 26, 2019
Bone and hormonal status 10 years post-allogeneic bone marrow transplantationDanica Gubrianska, Maciej Machaczka, Moustapha Hassan, et al.
Transplantation|April 16, 2004
Reduced risk for extensive chronic graft-versus-host disease in patients receiving transplants with human leukocyte antigen-identical sibling donors given polymerase chain reaction-based preemptive therapy against cytomegalovirusKajsa Larsson, Johan Aschan, Mats Remberger, et al.
Pediatric Blood & Cancer|July 11, 2020
A prospective study on the long-term outcome of prepubertal and pubertal boys undergoing testicular biopsy for fertility preservation prior to hematologic stem cell transplantationBirgit Borgström, Margareta Fridström, Britt Gustafsson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 18, 2016
Risk Factors for Invasive Mold Infections and Implications for Choice of Prophylaxis after Allogeneic Stem Cell TransplantationOla Blennow, Mats Remberger, Johan Törlén, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2014
Varicella-zoster reactivation after allogeneic stem cell transplantation without routine prophylaxis--the incidence remains highOla Blennow, Gustav Fjaertoft, Jacek Winiarski, et al.
Pageof 32